New Brunswick, NJ - According to Craig McCarthy, "Johnson & Johnson will be the first company to seek formal advice on providing experimental drugs to the desperately ill -- or "compassionate use"-- before they are approved, reports say. The New Jersey-based drug company appointed a bioethicist Thursday to create a panel, according to The New York Times, charged with making decisions for patient's request for the trial drugs."
The response to the current emotional debate, given the company's size, could influence others to follow suit, the report says.
The panel's decision will be just a recommendation with Johnson & Johnson making the final determination, according to Furtune, but says the company must "a rationale if they disagree."
The Food and Drug Administration set up a process for patients to get drugs in trial in the 1980s during the AIDS epidemic, the NYT reports.
However, the company must still agree, weighing the risk to possibly cause more harm to the patient and to the drug's approval process.
For the full story: http://www.nj.com/news/index.ssf/2015/05/johnson_johnson_to_create_panel_for_experimental_drugs_reports_say.html
The panel's decision will be just a recommendation with Johnson & Johnson making the final determination, according to Furtune, but says the company must "a rationale if they disagree."
The Food and Drug Administration set up a process for patients to get drugs in trial in the 1980s during the AIDS epidemic, the NYT reports.
However, the company must still agree, weighing the risk to possibly cause more harm to the patient and to the drug's approval process.
For the full story: http://www.nj.com/news/index.ssf/2015/05/johnson_johnson_to_create_panel_for_experimental_drugs_reports_say.html
